Advances in CAR-T Cell Therapy Across Hematologic Malignancies: From Pipeline to Clinical Practice

Download this slideset for expert perspectives on current best practices and emerging strategies in the use of CAR T-cell therapy for patients with lymphomas.

Michael R. Bishop, MD Released: December 10, 2021

Download this slideset for expert perspectives on optimal strategies in the use of CAR T-cell therapy for patients with multiple myeloma.

Jesús G. Berdeja, MD Released: December 10, 2021

Download this slideset for expert perspectives on current best practices and emerging strategies in the use of CAR T-cell therapy for patients with ALL, as well as a discussion of key toxicities associated with CAR T-cell therapy.

Jae H. Park, MD Released: December 10, 2021

Download this short summary slideset of key takeaway points from a live presentation on current best practices and emerging strategies in the use of CAR T-cell therapy.

Jesús G. Berdeja, MD Michael R. Bishop, MD Jae H. Park, MD Released: December 20, 2021

In this on-demand webcast of a live satellite symposium, expert faculty review the latest safety and efficacy data on CAR T-cell–based therapies for leukemias, lymphomas, and myeloma.

Michael R. Bishop, MD
Program Director Jesús G. Berdeja, MD Jae H. Park, MD Physicians: maximum of 2.25 AMA PRA Category 1 Credits™ Released: January 13, 2022 Expired: No longer available for credit